Nifty
:
23587.50
Sensex
:
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)
Nifty
Sensex
:
:
23587.50
78041.59
-364.20 (-1.52%)
-1176.46 (-1.49%)

Sudarshan Pharma Industries Ltd.

Pharmaceuticals & Drugs

Rating :
N/A

BSE: 543828 | NSE: Not Listed

NSE BSE
40.40
20-Dec-2024
  • Open
  • High
  • Low
  • Previous Close
  •  41.96
  •  41.96
  •  40.40
  •  41.22
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  96000
  •  39.58
  •  46.00
  •  5.82

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 972.26
  • 84.88
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,076.96
  • N/A
  • 8.70

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 57.39%
  • 4.28%
  • 23.21%
  • FII
  • DII
  • Others
  • 13.07%
  • 0.00%
  • 2.05%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

Quarterly Results

N/A

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
-
463.54
461.33
357.09
193.35
Net Sales Growth
-
0.48%
29.19%
84.69%
 
Cost Of Goods Sold
-
422.94
430.72
335.10
177.59
Gross Profit
-
40.60
30.62
21.99
15.76
GP Margin
-
8.76%
6.64%
6.16%
8.15%
Total Expenditure
-
440.73
446.64
346.18
186.19
Power & Fuel Cost
-
0.08
0.04
0.00
0.00
% Of Sales
-
0.02%
0.01%
0%
0%
Employee Cost
-
2.68
2.08
1.68
1.38
% Of Sales
-
0.58%
0.45%
0.47%
0.71%
Manufacturing Exp.
-
3.54
4.79
2.80
1.70
% Of Sales
-
0.76%
1.04%
0.78%
0.88%
General & Admin Exp.
-
5.57
3.93
2.75
2.01
% Of Sales
-
1.20%
0.85%
0.77%
1.04%
Selling & Distn. Exp.
-
5.78
4.66
3.75
3.50
% Of Sales
-
1.25%
1.01%
1.05%
1.81%
Miscellaneous Exp.
-
0.14
0.44
0.10
0.00
% Of Sales
-
0.03%
0.10%
0.03%
0%
EBITDA
-
22.81
14.69
10.91
7.16
EBITDA Margin
-
4.92%
3.18%
3.06%
3.70%
Other Income
-
2.61
1.12
0.46
0.38
Interest
-
8.94
5.40
3.38
3.23
Depreciation
-
1.24
0.91
0.87
0.74
PBT
-
15.23
9.50
7.14
3.57
Tax
-
3.77
2.46
1.89
0.90
Tax Rate
-
24.75%
25.89%
26.47%
25.21%
PAT
-
11.46
7.04
5.25
2.67
PAT before Minority Interest
-
11.46
7.04
5.25
2.67
Minority Interest
-
0.00
0.00
0.00
0.00
PAT Margin
-
2.47%
1.53%
1.47%
1.38%
PAT Growth
-
62.78%
34.10%
96.63%
 
EPS
-
4.76
2.92
2.18
1.11

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
111.71
100.97
29.78
22.51
Share Capital
24.07
24.07
9.75
9.55
Total Reserves
87.64
76.91
20.03
12.96
Non-Current Liabilities
10.59
13.03
5.12
5.48
Secured Loans
9.06
11.78
4.08
2.82
Unsecured Loans
1.43
1.01
0.86
2.50
Long Term Provisions
0.09
0.06
0.04
0.03
Current Liabilities
160.82
118.48
102.62
71.22
Trade Payables
56.72
91.89
73.75
44.22
Other Current Liabilities
10.81
7.53
4.89
5.34
Short Term Borrowings
90.56
18.35
23.59
21.38
Short Term Provisions
2.74
0.71
0.39
0.28
Total Liabilities
283.12
232.48
137.52
99.26
Net Block
25.50
19.89
6.47
6.21
Gross Block
29.33
22.45
8.49
7.64
Accumulated Depreciation
3.83
2.56
2.03
1.42
Non Current Assets
41.55
33.86
7.94
11.62
Capital Work in Progress
1.88
0.01
0.54
0.00
Non Current Investment
12.34
12.34
0.00
0.00
Long Term Loans & Adv.
1.83
1.62
0.94
5.40
Other Non Current Assets
0.00
0.00
0.00
0.00
Current Assets
241.57
198.62
129.58
87.64
Current Investments
1.50
0.00
0.00
0.00
Inventories
85.74
74.57
46.87
23.96
Sundry Debtors
122.55
81.51
73.48
60.39
Cash & Bank
0.14
11.72
0.24
1.25
Other Current Assets
31.64
1.09
0.45
0.43
Short Term Loans & Adv.
21.92
29.74
8.55
1.60
Net Current Assets
80.75
80.14
26.96
16.42
Total Assets
283.12
232.48
137.52
99.26

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
6.01
-28.79
-3.82
2.77
PBT
15.23
9.50
7.14
3.57
Adjustment
9.40
5.82
4.05
3.94
Changes in Working Capital
-16.46
-42.00
-13.24
-3.91
Cash after chg. in Working capital
8.17
-26.69
-2.05
3.61
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-2.15
-2.11
-1.77
-0.84
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-5.49
-25.65
-1.46
-1.29
Net Fixed Assets
-3.78
-13.43
-1.39
Net Investments
-4.50
-12.34
-0.01
Others
2.79
0.12
-0.06
Cash from Financing Activity
-12.10
65.93
4.26
-1.49
Net Cash Inflow / Outflow
-11.58
11.48
-1.02
-0.01
Opening Cash & Equivalents
11.72
0.24
1.25
1.27
Closing Cash & Equivalent
0.14
11.72
0.24
1.25

Financial Ratios

Standalone /

Consolidated
Description
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
4.64
4.20
30.54
23.58
ROA
4.44%
3.80%
4.43%
2.69%
ROE
10.77%
10.76%
20.08%
11.87%
ROCE
13.75%
15.25%
18.67%
13.01%
Fixed Asset Turnover
17.90
29.82
44.28
25.32
Receivable days
80.34
61.31
68.42
114.01
Inventory Days
63.12
48.04
36.20
45.24
Payable days
64.12
70.18
64.25
90.88
Cash Conversion Cycle
79.33
39.17
40.37
68.37
Total Debt/Equity
0.94
0.34
1.03
1.32
Interest Cover
2.70
2.76
3.11
2.11

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017

News Update:


  • Sudarshan Pharma gets nod to acquire stake in Sudarshan Pharma Industries, Singapore
    30th Nov 2024, 12:43 PM

    The acquisition will help the company to expand its business operations in Singapore and other neighbouring countries

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.